Stay updated on Clinical Trial of KB103 for DEB Patients
Sign up to get notified when there's something new on the Clinical Trial of KB103 for DEB Patients page.

Latest updates to the Clinical Trial of KB103 for DEB Patients page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedIntroduces a Locations section with California as a study site and updates the revision to v3.3.3. The previous California Locations entry and the HHS Vulnerability Disclosure link were removed.SummaryDifference0.2%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedPublication section includes a minor wording update clarifying that publications are provided voluntarily and relate to the study results. A revision tag was added (Revision: v3.3.2) and the previous tag (Revision: v3.2.0) was removed.SummaryDifference0.1%

- Check50 days agoChange DetectedThe deletion removes a site-wide notice about government funding status and NIH Clinical Center operations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check65 days agoChange DetectedThe new screenshot shows only minor UI changes with no changes to core study details, objectives, inclusion criteria, or reported outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check93 days agoChange DetectedAdd: new government operating-status notice, a new resource entry for Epidermolysis bullosa dystrophica, and version to v3.2.0. Delete: version v3.1.0.SummaryDifference5%

- Check101 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial of KB103 for DEB Patients
Enter your email address, and we'll notify you when there's something new on the Clinical Trial of KB103 for DEB Patients page.